Thursday, October 22, 2026

12:45 PM - 1:45 PM

---

Details

12:55pm - 1:00pm Stephen Blakeney, Affinyx - Affiinyx – Biomarker-based based sperm selection 1:00pm - 1:05pm Dianna McKiernan, Ternaryx - Targeted protein degradation in autoimmune disease 1:05pm - 1:10pm Eliana Marino, ImmunoBiota - 9.5 Million People Live with Type 1 Diabetes. We’re Developing a New Oral Therapy to Change it 1:10pm - 1:15pm Stuart Fraser, Culturon - Culturon: Binding the Unbindable 1:20pm - 1:30pm Dr Chris Booth, Convenor - Australian Life Science Angels Network (ALSAN)